New checkpoint gene demonstrates ability to supercharge immune cells against cancer

byUniversity of Minnesota Medical SchoolGraphical abstract. Credit:Med(2022). DOI: 10.1016/j.medj.2022.07.008University of Minnesota researchers and their collaborators at the Nation

Updated on: January 12,2024 10

New checkpoint gene demonstrates ability to supercharge immune cells against cancer

byUniversity of Minnesota Medical SchoolGraphical abstract. Credit:Med(2022). DOI: 10.1016/j.medj.2022.07.008University of Minnesota researchers and their collaborators at the Nation

Updated on:January 12,2024 10

New test shows promise for detecting hard-to-find cervical cancers

byAlbert Einstein College of MedicineCredit: Unsplash/CC0 Public DomainIn findings with potentially important implications for cervical cancer screening, scientists at the Montefiore Einstein Ca

Updated on: January 12,2024 10

New test shows promise for detecting hard-to-find cervical cancers

byAlbert Einstein College of MedicineCredit: Unsplash/CC0 Public DomainIn findings with potentially important implications for cervical cancer screening, scientists at the Montefiore Einstein Ca

Updated on:January 12,2024 10

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on: January 12,2024 10

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on:January 12,2024 10

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on: January 12,2024 15

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on:January 12,2024 15

New computational tool identifies novel targets for cancer immunotherapy

byChildren's Hospital of PhiladelphiaIRIS: A big-data informed computational platform for discovering AS-derived cancer immunotherapy targets. Overall workflow of IRIS, computational modules

Updated on: January 12,2024 6

New computational tool identifies novel targets for cancer immunotherapy

byChildren's Hospital of PhiladelphiaIRIS: A big-data informed computational platform for discovering AS-derived cancer immunotherapy targets. Overall workflow of IRIS, computational modules

Updated on:January 12,2024 6

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on: January 12,2024 10

New computational approach increases accessibility to single-cell tumor profiling to improve treatment outcomes

by Ana María Rodríguez, Ph.D.,Baylor College of MedicineCredit:Genome Biology(2023). DOI: 10.1186/s13059-023-03016-6To improve therapies for cancer and other diseases, researchers st

Updated on:January 12,2024 10

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on: January 12,2024 10

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on:January 12,2024 10

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

byEmory UniversityResponder tumor to ICI has less tortuous vessel branches compared to nonresponder. (A and B) CT scans of a responder and nonresponder to IO with corresponding 3D rendering of t

Updated on: January 12,2024 9

New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

byEmory UniversityResponder tumor to ICI has less tortuous vessel branches compared to nonresponder. (A and B) CT scans of a responder and nonresponder to IO with corresponding 3D rendering of t

Updated on:January 12,2024 9

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

Updated on: January 12,2024 16

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

Updated on:January 12,2024 16

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024 15

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024 15

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on: January 11,2024 15

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on:January 11,2024 15

New machine-learning method may aid personalized cancer therapy

byJohns Hopkins University School of MedicineExperimental procedure. The procedure includes presentation training, immunogenicity transfer learning and independent evaluation on multiple dataset

Updated on: January 11,2024 15

New machine-learning method may aid personalized cancer therapy

byJohns Hopkins University School of MedicineExperimental procedure. The procedure includes presentation training, immunogenicity transfer learning and independent evaluation on multiple dataset

Updated on:January 11,2024 15